Additivity predicts the efficacy of most approved combination therapies for advanced cancer

This contains data related to the publication "Additivity predicts the efficacy of most approved combination therapies for advanced cancer".Input sheets:placebo_input_sheet.txtapproved_combination_trial_sheet.txtall_phase_combination_trial_sheet.txtSource data:Digitized Kaplan-Meier PFS curvesImputed individual patient dataClinical trial informationExperimental data (cell lines and PDX)Analyzed dataPairwise correlation in drug response from CTRPv2HSA/Additivity predictions (PFS_prediction.zip)Source data are contained within all_phase3_trials.zip, approved_trials.zip, placebo.zip, and experimental.zip. More information about the clinical trial sources can be found in the supplementary information and supplementary tables accompanying the publication. Please note that First Scan Time marked as 9999 in input sheets indicates trials that did not disclose the scan interval. <br><br><br>